SCHEMBL7960563

SCHEMBL7960563

CC(C)C[C@@H](C(=O)NN1CC(=O)NC1=O)[C@H](CC=Cc1ccccc1)C(=O)NOC1CCCCO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 2/20 0.39
TGFBR1 P36897 1/20 0.33
APP P05067 2/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CASP1 P29466 1/20 0.32
CASP3 P42574 1/20 0.32
CASP7 P55210 1/20 0.32
CASP6 P55212 1/20 0.32
CASP8 Q14790 1/20 0.32
P2RX3 P56373 1/20 0.31
MMP9 P14780 4/20 0.31
MMP2 P08253 3/20 0.31
ANPEP P15144 2/20 0.31
LTA4H P09960 1/20 0.31
LAP3 P28838 1/20 0.31
NPEPPS P55786 1/20 0.31
ERAP2 Q6P179 1/20 0.31
ERAP1 Q9NZ08 1/20 0.31
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7839914 1.00 ADAM17 (0.39) ADAM17TGFBR1APPMEN1KMT2A
SCHEMBL7955132 0.85 ADAM17 (0.44) ADAM17TGFBR1APPCASP1CASP3
SCHEMBL7835552 0.85 ADAM17 (0.44) ADAM17TGFBR1APPCASP1CASP3
SCHEMBL7828157 0.85 ADAM17 (0.39) ADAM17TGFBR1APPMEN1KMT2A
SCHEMBL6946530 0.85 ADAM17 (0.40) ADAM17TGFBR1APPMEN1KMT2A
SCHEMBL6946529 0.85 ADAM17 (0.40) ADAM17TGFBR1APPMEN1KMT2A
SCHEMBL7840552 0.84 ADAM17 (0.37) ADAM17TGFBR1APPMEN1KMT2A
SCHEMBL7957347 0.84 ADAM17 (0.38) ADAM17TGFBR1APPP2RX3MMP9
SCHEMBL7957348 0.84 ADAM17 (0.38) ADAM17TGFBR1APPP2RX3MMP9
SCHEMBL7837114 0.84 ADAM17 (0.37) ADAM17TGFBR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281363-B1 ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; AUTOIMMUNE DISORDERS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed